Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Net Margin (2024 - 2025)

Historic Net Margin for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to 52.14%.

  • Beta Bionics' Net Margin rose 86300.0% to 52.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.03%, marking a year-over-year decrease of 15600.0%. This contributed to the annual value of 63.48% for FY2024, which is 2205800.0% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Net Margin is 52.14%, which was up 86300.0% from 72.58% recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Net Margin ranged from a high of 52.14% in Q3 2025 and a low of 91.88% during Q1 2025